Mesoblast (ASX:MSB) today announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation for remestemcel-L in the treatment of acute respiratory distress syndrome (ARDS) due to Covid-19 infection..
Fast Track designation is granted if a therapy demonstrates the potential to address unmet medical needs for a serious or life-threatening disease.
ARDS is the primary cause of death in patients with Covid-19.
Shares in Mesoblast (ASX:MSB) are trading 0.3 per cent lower at $20.23.
28 Jul 2020 - Westpac (ASX:WBC) appoints Scott Collary as its new COO, its Group Executive Gary Thursby is set to depart, and announces a new Group Operating Office.
26 Apr 2023 - Emma Fisher, Portfolio Manager, provides her views on the current market environment and discusses her recent trip to Europe where she visited the Headquarters of CSL and QBE Insurance, which are two holdings in the Airlie Australian Share Fund.
12 Aug 2021 - A snapshot of the stocks on the move featuring National Australia Bank's (ASX:NAB) Q3 update along with headlines from Commonwealth Bank (ASX:CBA), Suncorp (ASX:SUN) and Westpac (ASX:WBC).
12 Dec 2019 - Employment platform SEEK (ASX:SEK) will issue A$150 mIllion of Floating Rate Subordinated Notes with a quarterly coupon of 3 month BBSW + 3.70 per cent.
14 Jan 2021 - Pilbara Minerals (ASX:PLS) has raised approximately $60.6 million for their retail entitlement offer to help support the acquisition of all the shares in Altura Lithium Operations.
20 Aug 2020 - The ACCC will not oppose Metcash’s (ASX:MTS) acquisition of a 70 per cent majority interest in Total Tools Holdings, the franchisor of the Total Tools network.
25 Jan 2024 - A snapshot of the stocks on the move, featuring EV Resources (ASX:EVR), Antilles Gold (ASX:AAU, OTCQB:ANTMF) and Respiri (ASX:RSH; OTCQB: RSHUF).
